{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:10:13Z","timestamp":1761844213847,"version":"build-2065373602"},"reference-count":55,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T00:00:00Z","timestamp":1643241600000},"content-version":"vor","delay-in-days":3193,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mucosalimmunology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mucosal Immunology"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1038\/mi.2012.103","type":"journal-article","created":{"date-parts":[[2012,11,7]],"date-time":"2012-11-07T08:28:27Z","timestamp":1352276907000},"page":"612-625","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Differentially imprinted innate immunity by mucosal boost vaccination determines antituberculosis immune protective outcomes, independent of T-cell immunity"],"prefix":"10.1016","volume":"6","author":[{"given":"M","family":"Jeyanathan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Damjanovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C R","family":"Shaler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Wortzman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Zganiacz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B D","family":"Lichty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/mi.2012.103_bib1","first-page":"23","article-title":"Prime-boost immunization strategies for infectious diseases","volume":"4,","author":"McShane","year":"2002","journal-title":"Curr. Opin. Mol. Ther."},{"key":"10.1038\/mi.2012.103_bib2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/978-1-4419-5632-3_7","article-title":"Strategies and implications for prime\u2013boost vaccination to generate memory CD8 T cells","volume":"780,","author":"Nolz","year":"2011","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1038\/mi.2012.103_bib3","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.it.2003.11.009","article-title":"Jump-starting the immune system: prime-boosting comes of age","volume":"25,","author":"Woodland","year":"2004","journal-title":"Trends Immunol."},{"key":"10.1038\/mi.2012.103_bib4","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nrmicro2240","article-title":"Viruses as vaccine vectors for infectious diseases and cancer","volume":"8,","author":"Draper","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1038\/mi.2012.103_bib5","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.coi.2011.03.006","article-title":"Viral vectors as vaccine platforms: deployment in sight","volume":"23,","author":"Rollier","year":"2011","journal-title":"Curr. Opin. Immunol."},{"key":"10.1038\/mi.2012.103_bib6","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2174\/156652305774329230","article-title":"Recent advances in the development of adenovirus- and poxvirus-vectored tuberculosis vaccines","volume":"5,","author":"Xing","year":"2005","journal-title":"Curr. Gene Ther."},{"key":"10.1038\/mi.2012.103_bib7","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1586\/erv.09.14","article-title":"Heterologous prime\u2013boost vaccinations for poverty-related diseases: advantages and future prospects","volume":"8,","author":"Radosevic","year":"2009","journal-title":"Expert Rev. Vaccines"},{"key":"10.1038\/mi.2012.103_bib8","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1586\/erv.10.106","article-title":"Prime\u2013boost immunization with poxvirus or adenovirus vectors as a strategy to develop a protective vaccine for HIV-1","volume":"9,","author":"Paris","year":"2010","journal-title":"Expert Rev. Vaccines"},{"issue":"Suppl","key":"10.1038\/mi.2012.103_bib9","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1038\/nm1213","article-title":"Mucosal immunity and vaccines","volume":"11","author":"Holmgren","year":"2005","journal-title":"Nat. Med."},{"key":"10.1038\/mi.2012.103_bib10","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1586\/erv.09.86","article-title":"Genetic heterologous prime\u2013boost vaccination strategies for improved systemic and mucosal immunity","volume":"8,","author":"Ranasinghe","year":"2009","journal-title":"Expert Rev. Vaccines"},{"key":"10.1038\/mi.2012.103_bib11","doi-asserted-by":"crossref","first-page":"6883","DOI":"10.4049\/jimmunol.0901466","article-title":"What role does the route of immunization play in the generation of protective immunity against mucosal pathogens?","volume":"183,","author":"Belyakov","year":"2009","journal-title":"J. Immunol."},{"key":"10.1038\/mi.2012.103_bib12","doi-asserted-by":"crossref","first-page":"4512","DOI":"10.1073\/pnas.96.8.4512","article-title":"Mucosal vaccination overcomes the barrier to recombinant vaccinia immunization caused by preexisting poxvirus immunity","volume":"96,","author":"Belyakov","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1038\/mi.2012.103_bib13","doi-asserted-by":"crossref","first-page":"e3548","DOI":"10.1371\/journal.pone.0003548","article-title":"Nasal delivery of an adenovirus-based vaccine bypasses pre-existing immunity to the vaccine carrier and improves the immune response in mice","volume":"3,","author":"Croyle","year":"2008","journal-title":"PLoS One"},{"key":"10.1038\/mi.2012.103_bib14","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.coi.2009.06.004","article-title":"T cells in mycobacterial infection and disease","volume":"21,","author":"Cooper","year":"2009","journal-title":"Curr. Opin. Immunol."},{"key":"10.1038\/mi.2012.103_bib15","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.it.2010.05.002","article-title":"Airway luminal T cells: a newcomer on the stage of TB vaccination strategies","volume":"31,","author":"Jeyanathan","year":"2010","journal-title":"Trends Immunol."},{"key":"10.1038\/mi.2012.103_bib16","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nri2274","article-title":"T-cell quality in memory and protection: implications for vaccine design","volume":"8,","author":"Seder","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1038\/mi.2012.103_bib17","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/mi.2011.10","article-title":"Initiation and regulation of T-cell responses in tuberculosis","volume":"4,","author":"Urdahl","year":"2011","journal-title":"Mucosal Immunol."},{"key":"10.1038\/mi.2012.103_bib18","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.coi.2009.05.017","article-title":"Tuberculosis vaccine research: the impact of immunology","volume":"21,","author":"Barker","year":"2009","journal-title":"Curr. Opin. Immunol."},{"key":"10.1038\/mi.2012.103_bib19","doi-asserted-by":"crossref","first-page":"e145","DOI":"10.1371\/journal.pmed.0050145","article-title":"Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations","volume":"5,","author":"Hanekom","year":"2008","journal-title":"PLoS Med."},{"key":"10.1038\/mi.2012.103_bib20","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.4161\/hv.6.12.13143","article-title":"First in humans: a new molecularly defined vaccine shows excellent safety and strong induction of long-lived Mycobacterium tuberculosis-specific Th1-cell like responses","volume":"6,","author":"Ottenhoff","year":"2010","journal-title":"Hum. Vaccine"},{"key":"10.1038\/mi.2012.103_bib21","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1172\/JCI40817","article-title":"Intranasal poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte\/macrophage population","volume":"120,","author":"Antonelli","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1038\/mi.2012.103_bib22","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1084\/jem.20091473","article-title":"Preexisting helminth infection induces inhibition of innate pulmonary anti-tuberculosis defense by engaging the IL-4 receptor pathway","volume":"208,","author":"Potian","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1038\/mi.2012.103_bib23","doi-asserted-by":"crossref","first-page":"628293","DOI":"10.1155\/2012\/628293","article-title":"Understanding delayed T-cell priming, lung recruitment, and airway luminal T-cell responses in host defense against pulmonary tuberculosis","volume":"2012,","author":"Shaler","year":"2012","journal-title":"Clin. Dev. Immunol."},{"key":"10.1038\/mi.2012.103_bib24","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1172\/JCI18991","article-title":"TNF-alpha is a critical negative regulator of type 1 immune activation during intracellular bacterial infection","volume":"113,","author":"Zganiacz","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1038\/mi.2012.103_bib25","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nri1777","article-title":"Mucosal vaccines: the promise and the challenge","volume":"6,","author":"Neutra","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1038\/mi.2012.103_bib26","doi-asserted-by":"crossref","first-page":"6290","DOI":"10.4049\/jimmunol.172.10.6290","article-title":"Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity","volume":"172,","author":"Barouch","year":"2004","journal-title":"J. Immunol."},{"key":"10.1038\/mi.2012.103_bib27","doi-asserted-by":"crossref","first-page":"6305","DOI":"10.1128\/JVI.77.11.6305-6313.2003","article-title":"Comparative immunogenicity in rhesus monkeys of DNA plasmid, recombinant vaccinia virus, and replication-defective adenovirus vectors expressing a human immunodeficiency virus type 1 gag gene","volume":"77,","author":"Casimiro","year":"2003","journal-title":"J. Virol."},{"key":"10.1038\/mi.2012.103_bib28","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/415331a","article-title":"Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity","volume":"415,","author":"Shiver","year":"2002","journal-title":"Nature"},{"key":"10.1038\/mi.2012.103_bib29","doi-asserted-by":"crossref","first-page":"7986","DOI":"10.4049\/jimmunol.174.12.7986","article-title":"Mechanisms of mucosal and parenteral tuberculosis vaccinations: adenoviral-based mucosal immunization preferentially elicits sustained accumulation of immune protective CD4 and CD8 T cells within the airway lumen","volume":"174,","author":"Santosuosso","year":"2005","journal-title":"J. Immunol."},{"key":"10.1038\/mi.2012.103_bib30","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/mt.2008.59","article-title":"Heterologous boosting of recombinant adenoviral prime immunization with a novel vesicular stomatitis virus-vectored tuberculosis vaccine","volume":"16,","author":"Roediger","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1038\/mi.2012.103_bib31","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1172\/JCI200421027","article-title":"Fatal Mycobacterium tuberculosis infection despite adaptive immune response in the absence of MyD88","volume":"114,","author":"Fremond","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1038\/mi.2012.103_bib32","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/mi.2011.13","article-title":"Role of innate cytokines in mycobacterial infection","volume":"4,","author":"Cooper","year":"2011","journal-title":"Mucosal Immunol."},{"key":"10.1038\/mi.2012.103_bib33","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1172\/JCI6224","article-title":"Macrophages are a significant source of type 1 cytokines during mycobacterial infection","volume":"103,","author":"Wang","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1038\/mi.2012.103_bib34","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1189\/jlb.68.6.897","article-title":"Role of IL-12 in macrophage activation during intracellular infection: IL-12 and mycobacteria synergistically release TNF-alpha and nitric oxide from macrophages via IFN-gamma induction","volume":"68,","author":"Xing","year":"2000","journal-title":"J. Leukoc. Biol."},{"key":"10.1038\/mi.2012.103_bib35","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/mi.2011.7","article-title":"The role of IL-10 in immune regulation during M. tuberculosis infection","volume":"4,","author":"Redford","year":"2011","journal-title":"Mucosal Immunol."},{"key":"10.1038\/mi.2012.103_bib36","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1586\/ers.10.81","article-title":"Pulmonary mucosal dendritic cells in T-cell activation: implications for TB therapy","volume":"5,","author":"McCormick","year":"2011","journal-title":"Expert Rev. Respir. Med."},{"key":"10.1038\/mi.2012.103_bib37","first-page":"423","article-title":"The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection","volume":"84,","author":"Cooper","year":"1995","journal-title":"Immunology"},{"key":"10.1038\/mi.2012.103_bib38","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1002\/1521-4141(200107)31:7<2026::AID-IMMU2026>3.0.CO;2-U","article-title":"Type I interferons and IL-12: convergence and cross-regulation among mediators of cellular immunity","volume":"31,","author":"Byrnes","year":"2001","journal-title":"Eur. J. Immunol."},{"key":"10.1038\/mi.2012.103_bib39","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1073\/pnas.94.2.634","article-title":"Interferon-alpha\/beta inhibition of interleukin 12 and interferon-gamma production in vitro and endogenously during viral infection","volume":"94,","author":"Cousens","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1038\/mi.2012.103_bib40","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1084\/jem.20091746","article-title":"Induction of IFN-alphabeta enables Listeria monocytogenes to suppress macrophage activation by IFN-gamma","volume":"207,","author":"Rayamajhi","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1038\/mi.2012.103_bib41","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tube.2006.01.017","article-title":"Use of recombinant virus-vectored tuberculosis vaccines for respiratory mucosal immunization","volume":"86,","author":"Xing","year":"2006","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1038\/mi.2012.103_bib42","doi-asserted-by":"crossref","first-page":"6919","DOI":"10.4049\/jimmunol.179.10.6919","article-title":"Progression of pulmonary tuberculosis and efficiency of bacillus Calmette\u2013Guerin vaccination are genetically controlled via a common sst1-mediated mechanism of innate immunity","volume":"179,","author":"Yan","year":"2007","journal-title":"J. Immunol."},{"key":"10.1038\/mi.2012.103_bib43","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.tube.2008.06.005","article-title":"A comparison of IFNgamma detection methods used in tuberculosis vaccine trials","volume":"88,","author":"Beveridge","year":"2008","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1038\/mi.2012.103_bib44","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1513\/pats.200706-066TH","article-title":"Respiratory infections: do we ever recover?","volume":"4,","author":"Goulding","year":"2007","journal-title":"Proc. Am. Thorac. Soc."},{"key":"10.1038\/mi.2012.103_bib45","doi-asserted-by":"crossref","first-page":"9843","DOI":"10.1073\/pnas.0911932107","article-title":"Innate and adaptive immune correlates of vaccine and adjuvant-induced control of mucosal transmission of SIV in macaques","volume":"107,","author":"Sui","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1038\/mi.2012.103_bib46","doi-asserted-by":"crossref","first-page":"6357","DOI":"10.4049\/jimmunol.173.10.6357","article-title":"Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis","volume":"173,","author":"Wang","year":"2004","journal-title":"J. Immunol."},{"key":"10.1038\/mi.2012.103_bib47","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1086\/426395","article-title":"Macrophages play a dual role during pulmonary tuberculosis in mice","volume":"191,","author":"Leemans","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1038\/mi.2012.103_bib48","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/icb.2010.162","article-title":"Versatility in NK cell memory","volume":"89,","author":"Sun","year":"2011","journal-title":"Immunol. Cell. Biol."},{"key":"10.1038\/mi.2012.103_bib49","doi-asserted-by":"crossref","first-page":"5752","DOI":"10.1073\/pnas.091096998","article-title":"Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha\/beta","volume":"98,","author":"Manca","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1038\/mi.2012.103_bib50","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1089\/jir.2005.25.694","article-title":"Hypervirulent M. tuberculosis W\/Beijing strains upregulate type I IFNs and increase expression of negative regulators of the Jak-Stat pathway","volume":"25,","author":"Manca","year":"2005","journal-title":"J Interferon Cytokine Res."},{"key":"10.1038\/mi.2012.103_bib51","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1084\/jem.189.8.1315","article-title":"Two roads diverged: interferon alpha\/beta- and interleukin 12-mediated pathways in promoting T cell interferon gamma responses during viral infection","volume":"189,","author":"Cousens","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1038\/mi.2012.103_bib52","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.4049\/jimmunol.178.4.2387","article-title":"Mucosal luminal manipulation of T cell geography switches on protective efficacy by otherwise ineffective parenteral genetic immunization","volume":"178,","author":"Santosuosso","year":"2007","journal-title":"J. Immunol."},{"key":"10.1038\/mi.2012.103_bib53","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.1128\/IAI.00517-06","article-title":"Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary tuberculosis","volume":"74,","author":"Santosuosso","year":"2006","journal-title":"Infect. Immun."},{"key":"10.1038\/mi.2012.103_bib54","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1471-2172-9-48","article-title":"CD11c+ antigen presenting cells from the alveolar space, lung parenchyma and spleen differ in their phenotype and capabilities to activate naive and antigen-primed T cells","volume":"9,","author":"Kugathasan","year":"2008","journal-title":"BMC Immunol."},{"key":"10.1038\/mi.2012.103_bib55","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1089\/vim.2005.18.283","article-title":"Adenoviral vectors for mucosal vaccination against infectious diseases","volume":"18,","author":"Santosuosso","year":"2005","journal-title":"Viral Immunol."}],"container-title":["Mucosal Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/mi2012103.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/mi2012103","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193302192201220X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193302192201220X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/mi2012103.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T13:23:42Z","timestamp":1761830622000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S193302192201220X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S193302192201220X"],"URL":"https:\/\/doi.org\/10.1038\/mi.2012.103","relation":{},"ISSN":["1933-0219"],"issn-type":[{"type":"print","value":"1933-0219"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differentially imprinted innate immunity by mucosal boost vaccination determines antituberculosis immune protective outcomes, independent of T-cell immunity","name":"articletitle","label":"Article Title"},{"value":"Mucosal Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/mi.2012.103","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1038\/mi.2013.22","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 \u00a9 Society for Mucosal Immunology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}